Kamada (KMDA) Operating Expenses (2012 - 2026)
Kamada (KMDA) posted quarterly Operating Expenses of $7.4 million for Q1 2026, down 12.25% year-on-year from $8.4 million in Q1 2025, and down 13.17% on a QoQ basis from $8.5 million in Q4 2025.
Kamada (KMDA) Operating Expenses (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Operating Expenses for 15 consecutive years, with $7.4 million the latest figure, recorded in Q1 2026.
- Quarterly Operating Expenses fell 12.25% year-over-year to $7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.4 million (changed 0.49% YoY) and the FY2025 annual result came in at $31.7 million, up 0.73% from the prior year.
- Operating Expenses slipped to $7.4 million in Q1 2026 per KMDA's latest filing, from $8.5 million in the prior quarter.
- Over the last five years, Operating Expenses for KMDA reached as high as $8.5 million in Q4 2025 and fell as low as $6283.0 in Q3 2022.
- A 5-year average of $5.6 million and a median of $7.4 million in 2024 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2023 — Operating Expenses tumbled 99.91% — and 2024, when it soared 121437.07%.
- Year by year, Operating Expenses stood at $6.3 million in 2022, then gained by 11.14% to $7.0 million in 2023, then gained by 5.29% to $7.4 million in 2024, then advanced by 15.53% to $8.5 million in 2025, then fell by 13.17% to $7.4 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $7.4 million, $8.5 million, and $7.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | 7.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.41 Mn |
| Dec 31, 2025 | 8.53 Mn |
| Sep 30, 2025 | 7.44 Mn |
| Jun 30, 2025 | 7,286.00 |
| Mar 31, 2025 | 8.44 Mn |
| Dec 31, 2024 | 7.39 Mn |
| Sep 30, 2024 | 7.44 Mn |
| Jun 30, 2024 | 8,581.00 |
| Mar 31, 2024 | 8.08 Mn |
| Dec 31, 2023 | 7.02 Mn |
| Sep 30, 2023 | 6.72 Mn |
| Jun 30, 2023 | 7.77 Mn |
| Mar 31, 2023 | 6,649.00 |
| Dec 31, 2022 | 6.31 Mn |
| Sep 30, 2022 | 6,283.00 |
| Jun 30, 2022 | 5.95 Mn |
| Mar 31, 2022 | 7.43 Mn |
| Dec 31, 2021 | 7.28 Mn |
| Sep 30, 2021 | 5.24 Mn |
| Jun 30, 2021 | 6.04 Mn |